PROCEPT BIOROBOTICS CORPORATION - COMMON STOCK

Aquablation Therapy is the first surgical robotics system to receive a MedTech Innovation Briefing (MIB) from the National Institute for Health Care Excellence

07 مارس 2023 06:00:01 بحسب Nasdaq GlobeNewswire

PROCEPT BioRobotics Corp. to Present at the Virtual Key Bank Life Sciences & MedTech Investor Forum

02 مارس 2023 15:05:00 بحسب Nasdaq GlobeNewswire

PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2022 Results

28 فبراير 2023 15:03:00 بحسب Nasdaq GlobeNewswire

PROCEPT BioRobotics Corp. to Present at the 43rd Annual Cowen Health Care Conference in Boston

13 فبراير 2023 15:02:00 بحسب Nasdaq GlobeNewswire

PROCEPT BioRobotics Announces Preliminary Fourth Quarter and Fiscal Year 2022 Revenue  

09 يناير 2023 07:00:01 بحسب Nasdaq GlobeNewswire

PROCEPT BioRobotics Corp. to Present at the 41st Annual J.P. Morgan Healthcare Conference

14 ديسمبر 2022 15:05:00 بحسب Nasdaq GlobeNewswire

PROCEPT BioRobotics Reports Third Quarter 2022 Financial Results and Increases 2022 Revenue Guidance

03 نوفمبر 2022 15:03:00 بحسب Nasdaq GlobeNewswire

PROCEPT BioRobotics to Report Third Quarter 2022 Financial Results on November 3, 2022

12 أكتوبر 2022 07:00:01 بحسب Nasdaq GlobeNewswire

PROCEPT BioRobotics Announces $52 Million Debt Refinancing

10 أكتوبر 2022 07:00:01 بحسب Nasdaq GlobeNewswire

Providence Advances Surgical Robotics Program with Multi-System, National Contract for PROCEPT BioRobotics AquaBeam Systems

19 سبتمبر 2022 07:00:01 بحسب Nasdaq GlobeNewswire

PROCEPT BioRobotics Corp. to Present at 2022 Wells Fargo Healthcare Conference

22 أغسطس 2022 15:03:00 بحسب Nasdaq GlobeNewswire

PROCEPT BioRobotics Reports Second Quarter 2022 Financial Results and Increases 2022 Revenue Guidance

04 أغسطس 2022 15:03:00 بحسب Nasdaq GlobeNewswire

PROCEPT BioRobotics to Report Second Quarter 2022 Financial Results on August 4, 2022

14 يوليو 2022 15:02:00 بحسب Nasdaq GlobeNewswire

PROCEPT BioRobotics Corporation Announces Additional Positive Coverage Policies Regarding Aquablation Therapy for Men with Enlarged Prostates

09 يونيو 2022 07:00:01 بحسب Nasdaq GlobeNewswire

PROCEPT BioRobotics Reports First Quarter 2022 Financial Results and Increases 2022 Revenue Guidance

05 مايو 2022 15:02:00 بحسب Nasdaq GlobeNewswire

PROCEPT BioRobotics Corporation Announces Aetna and Independence Blue Cross Blue Shield Positive Coverage Decisions Regarding Aquablation Therapy for Men with Enlarged Prostates

28 أبريل 2022 07:00:03 بحسب Nasdaq GlobeNewswire

PROCEPT BioRobotics Corp. to Report First Quarter 2022 Financial Results on May 5, 2022 and attend the 2022 Bank of America Healthcare Conference on May 11, 2022

12 أبريل 2022 15:02:00 بحسب Nasdaq GlobeNewswire

PROCEPT BioRobotics Corp. Announces Investor Event at 2022 AUA Annual Meeting in New Orleans

11 أبريل 2022 07:00:00 بحسب Nasdaq GlobeNewswire

PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2021 Financial Results

08 مارس 2022 06:00:00 بحسب Nasdaq GlobeNewswire

PROCEPT BioRobotics Corp. to Report Fourth Quarter and Full Year 2021 Financial Results on March 8, 2022

22 فبراير 2022 07:00:01 بحسب Nasdaq GlobeNewswire